VerAvanti Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $28.3M

  • Investors
  • 4

VerAvanti General Information

Description

Developer of a scanning fiber endoscope device designed to identify the causes of strokes and cardiac events. The company's device consists of an imaging station and a tiny catheter that is designed to take high-definition images, thereby enabling doctors and surgeons to have a peek into hidden intra-vascular anatomy and visually identify potential risks for stroke and cardiovascular risks.

Contact Information

Website
www.veravanti.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 22322 20th Avenue SouthEast
  • Suite 100
  • Bothell, WA 98021
  • United States
+1 (425)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 22322 20th Avenue SouthEast
  • Suite 100
  • Bothell, WA 98021
  • United States
+1 (425)

VerAvanti Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VerAvanti Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series A) 07-Mar-2025 $28.3M Completed Generating Revenue
7. Grant 23-Sep-2021 Completed Generating Revenue
6. Debt - PPP 29-Apr-2020 Completed Generating Revenue
5. Early Stage VC (Series A) 17-Jul-2017 Completed Generating Revenue
4. Grant 01-Jun-2017 Completed Generating Revenue
3. Angel (individual) 25-May-2017 Completed Generating Revenue
2. Accelerator/Incubator 28-Jun-2014 Completed Generating Revenue
1. University Spin-Out 01-Jan-2013 Completed Generating Revenue
To view VerAvanti’s complete valuation and funding history, request access »

VerAvanti Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view VerAvanti’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

VerAvanti Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • 7

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

VerAvanti Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210239451-A1 Forward looking rgb/optical coherence tomography duplex imager Active 30-Jan-2020
US-11047671-B1 Forward looking rgb/optical coherence tomography duplex imager Active 30-Jan-2020
US-11530910-B2 Forward looking rgb/optical coherence tomography duplex imager Active 30-Jan-2020
JP-2023514816-A Forward-looking rgb/optical coherence tomography dual imager Active 30-Jan-2020
US-20230184536-A1 Synchronizing an optical coherence tomography system Pending 30-Jan-2020 G01B9/02091
To view VerAvanti’s complete patent history, request access »

VerAvanti Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VerAvanti Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Cancer Institute Government
National Heart, Lung, and Blood Institute Government
UW CoMotion Accelerator/Incubator
University of Washington University
To view VerAvanti’s complete investors history, request access »

Ready to get started?

Request a free trial

VerAvanti FAQs

  • When was VerAvanti founded?

    VerAvanti was founded in 2013.

  • Where is VerAvanti headquartered?

    VerAvanti is headquartered in Bothell, WA.

  • What is the size of VerAvanti?

    VerAvanti has 14 total employees.

  • What industry is VerAvanti in?

    VerAvanti’s primary industry is Diagnostic Equipment.

  • Is VerAvanti a private or public company?

    VerAvanti is a Private company.

  • What is the current valuation of VerAvanti?

    The current valuation of VerAvanti is .

  • What is VerAvanti’s current revenue?

    The current revenue for VerAvanti is .

  • How much funding has VerAvanti raised over time?

    VerAvanti has raised $33.9M.

  • Who are VerAvanti’s investors?

    National Cancer Institute, National Heart, Lung, and Blood Institute, UW CoMotion, and University of Washington have invested in VerAvanti.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »